Core Viewpoint - The resignation of Dai Sijue, the chairman of Baolingbao, comes at a time of strong performance recovery for the company, raising questions about underlying financial pressures within the controlling shareholder's structure [5][6]. Company Overview - Baolingbao's stock price was reported at 10.86 yuan, with a market capitalization of 4.064 billion yuan as of November 17 [2]. - Dai Sijue, born in January 1995, became the youngest chairman in A-share market history at the age of 26 in March 2021 [3][6]. - His tenure lasted approximately four and a half years, during which he faced significant challenges, including industry fluctuations and an EU anti-dumping investigation [4][6]. Performance Analysis - Despite the challenges, Baolingbao demonstrated resilience, achieving a net profit of 111 million yuan in 2024, a year-on-year increase of 105.97%, and a significant rise in net profit excluding non-recurring items by 254.56% [8]. - For the first three quarters of 2025, the company reported revenue of 2.126 billion yuan, up 15.98%, and a net profit of 134 million yuan, reflecting a 32.58% increase year-on-year [8]. Shareholder Dynamics - The actual control of Baolingbao shifted in August 2024 from Dai Sijue alone to a joint control structure with his brother, Dai Sicong [10]. - A planned share buyback by the new controlling entity has faced delays due to "funding arrangements," with the initial commitment to increase holdings by 5% not being met [11][12]. - As of the resignation announcement, Dai Sijue held 29.5087 million shares through his investment firm, representing 7.75% of the total shares [13].

证券日报网讯11月17日晚间，保龄宝（002286）发布公告称，公司董事会于2025年11月17日收到公司董 事长戴斯觉先生的书面辞职报告。戴斯觉先生因个人原因申请辞去公司董事长、董事、董事会战略委员 会主任委员职务。 ...

Core Viewpoint - The resignation of Dai Sijue, the youngest chairman in A-share history, comes at a time when the company, Baolingbao, is experiencing a strong performance rebound, raising questions about underlying pressures within the company's control structure [1][2][3] Company Performance - Baolingbao reported a net profit of 111 million yuan for 2024, a year-on-year increase of 105.97%, and a significant increase in non-recurring net profit by 254.56% [3] - For the first three quarters of 2025, Baolingbao achieved a revenue of 2.126 billion yuan, up 15.98% year-on-year, and a net profit of 134 million yuan, reflecting a 32.58% increase [3] Industry Context - The erythritol industry faced severe supply-demand imbalances and price wars in 2023 due to an influx of new players, followed by an anti-dumping investigation by the European Union [3] - The company has shown resilience in navigating the industry's cyclical challenges, focusing on high-value products and optimizing supply chain management [3] Control Structure Changes - The actual control of Baolingbao shifted from Dai Sijue alone to a joint control with his brother, Dai Sicong, in August 2024 [5] - A promised share buyback plan by the new controlling entity has faced delays, with the initial commitment to increase holdings by 5% not being fulfilled as of the latest reports [6] Financial Pressures - Dai Sijue's controlling entity, Yongyu Investment, has faced significant financial pressures, being listed as an executor in multiple court cases with total amounts exceeding 280 million yuan [1][6] - As of the resignation announcement, Dai Sijue held 7.75% of Baolingbao's shares through Yongyu Investment, indicating ongoing involvement despite his resignation [6]

每经记者｜彭斐 每经编辑｜张益铭 "三十而立"的戴斯觉，选择在公司业绩强势反弹之际辞职。 辞职背后，保龄宝实控人层面的资金压力隐现。就在2024年，保龄宝变更为由戴斯觉、戴斯聪兄弟共同 控制，而由戴斯聪控制的企业所承诺的增持计划，因"资金安排"原因一再拖延。与此同时，戴斯觉本人 控制的控股股东北京永裕投资管理有限公司（以下简称"永裕投资"），年内已多次被列为被执行人，涉 及金额超2.8亿元。 曾经的A股"最年轻董事长"谢幕 根据保龄宝11月17日晚间的公告，戴斯觉因个人原因申请辞去公司董事长、董事、董事会战略委员会主 任委员职务。 公告称，戴斯觉的辞职不会导致公司董事会成员低于法定最低人数，辞职报告自送达董事会时生效。辞 职后，他仍将担任公司全资孙公司BLB INTERNATIONAL DEVELOPMENT(SINGAPORE)PTE.ITD.、 BLB BIO-TECH USA INC董事职务。 戴斯觉的"A股最年轻董事长"身份始于2021年。资料显示，戴斯觉出生于1995年1月，为中国香港居 民，拥有英国曼彻斯特大学金融经济学理学硕士学历。2021年3月25日，保龄宝召开第五届董事会第一 次会议，会议以 ...

截至本公告披露日，戴斯觉未直接持有公司股份，通过北京永裕投资管理有限公司持有公司29,508,653 股股票,占公司总股本的7.75%，戴斯觉为公司实际控制人之一。 11月17日，保龄宝发布公告称，公司董事会于2025年11月17日收到公司董事长戴斯觉的书面辞职报告。 戴斯觉因个人原因申请辞去公司董事长、董事、董事会战略委员会主任委员职务。戴斯觉辞职后 仍 担 任 公 司 全 资 孙公 司 BLB INTERNATIONAL DEVELOPMENT(SINGAPORE) PTE.ITD.、BLB BIO- TECH USA INC董事职务。 根据《公司章程》、《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》的有 关规定，戴斯觉的辞职不会导致公司董事会成员低于法定最低人数，不会影响公司董事会的正常运行及 公司正常生产经营工作，戴斯觉的辞职报告自送达公司董事会时生效。鉴于新任董事长的选举工作尚需 经过相应的法定程序，公司将按照法定程序尽快完成公司董事长的补选等相关工作，并及时履行信息披 露义务。 （企业公告） (编辑：王璨 林辰)关键字： 饮料 ...

格隆汇11月17日丨保龄宝(002286.SZ)公布，董事会于2025年11月17日收到公司董事长戴斯觉先生的书 面辞职报告。戴斯觉先生因个人原因申请辞去公司董事长、董事、董事会战略委员会主任委员职务。戴 斯觉先生辞职后仍担任公司全资孙公司 BLBINTERNATIONALDEVELOPMENT(SINGAPORE)PTE.ITD.、BLBBIO-TECHUSAINC董事职务。 ...

人民财讯11月17日电，保龄宝（002286）11月17日公告，戴斯觉因个人原因申请辞去公司董事长、董 事、董事会战略委员会主任委员职务。 ...

Group 1 - The chairman of Baolingbao, Dai Sijue, submitted his resignation due to personal reasons, effective November 17, 2025, while retaining positions in the company's wholly-owned subsidiaries [1] - Baolingbao's revenue composition for the first half of 2025 indicates that the food manufacturing sector accounts for 100% of its revenue [1] - As of the latest report, Baolingbao's market capitalization stands at 4.1 billion yuan [2]

保龄宝11月17日公告，公司董事会收到董事长戴斯觉的书面辞职报告，戴斯觉因个人原因申请辞去公司 董事长、董事等职务。戴斯觉辞职后仍担任公司全资孙公司BLB INTERNATIONAL DEVELOPMENT （SINGAPORE） PTE.ITD.、BLB BIO-TECH USA INC董事职务。戴斯觉的辞职报告自送达公司董事会 时生效。 ...

南财智讯11月17日电，保龄宝公告，公司董事会于2025年11月17日收到董事长戴斯觉先生的书面辞职报 告。戴斯觉先生因个人原因申请辞去公司董事长、董事、董事会战略委员会主任委员职务。戴斯觉先生 辞职后仍担任公司全资孙公司BLBINTERNATIONALDEVELOPMENT(SINGAPORE)PTE.ITD.、 BLBBIO-TECHUSAINC董事职务。根据相关规定，戴斯觉先生的辞职报告自送达公司董事会时生效。 公司将按照法定程序尽快完成董事长的补选等相关工作。截至公告披露日，戴斯觉先生未直接持有公司 股份，通过北京永裕投资管理有限公司持有公司29,508,653股股票，占公司总股本的7.75%，戴斯觉先 生为公司实际控制人之一。戴斯觉先生不存在应当履行而未履行的承诺事项。 ...